← All Sponsors
SPONSOR

Xuzhou Medical University

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Multiple Myeloma
NCT06759181 Phase 1, Phase 2
Recruiting

Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

Multiple Myeloma
China View Trial →